News
Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a ...
Privacy and information commissioners from Canada and the U.K. will reveal the findings of their investigation into the 23andMe data breach.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback